Intrinsic Therapeutics, Inc. Company Profile

05:01 EDT 26th September 2017 | BioPortfolio

Intrinsic Therapeutics is dedicated to treating soft-tissue injuries of the spine. Intrinsic's Barricaid anular reconstructive products are used during discectomy to definitively close defects in the posterior anulus. By restoring anular competence, the Barricaid family of products may reduce the risk of recurrent herniation while maintaining disc height and biomechanics.

News Articles [1563 Associated News Articles listed on BioPortfolio]

Intrinsic Therapeutics gets $49M boost

A round of debt and equity financing has pulled in $49 million for Boston-based Intrinsic Therapeutics.  -More- 

Intrinsic Therapeutics completes $49m financing

Intrinsic Therapeutics, a medical device company that has developed a product to improve outcomes in lumbar discectomy patients, has recently closed a $49m round of financing.

Intrinsic closes financing of equity and debt

Spinal device maker Intrinsic Therapeutics Inc. raised $28mm through a late-stage financing co-led by returning shareholder New Enterprise Associates and new backer Delos Capital (adds a board member)...

Boston's Intrinsic Therapeutics Snags $49 Million Financing

  Life Sciences Jobs   ...

Intrinsic Imaging Awarded a Validation Study for the Development of an Innovative Medical Device to Aid in the Evaluation of Gastrointestinal Motility

Intrinsic Imaging selected for its operational excellence and extensive therapeutic experience in imaging core lab services for medical devices. Bolton, MA, San Antonio, TX (PRWEB) June 27, 2017 Intr...

Intrinsic Imaging Awarded New Clinical Study to Evaluate Innovative Tumor Imaging Platform

Intrinsic Imaging selected for its deep breadth of experience in oncology and medical device trials. Bolton, MA, San Antonio, TX (PRWEB) July 06, 2017 Intrinsic Imaging, a full-service medical imagin...

Intrinsic Imaging Awarded Another Pivotal Multiple-Reader Multiple-Case (MRMC) Study to Assess the Clinical Performance of CAD Software

Intrinsic Imaging’s MRMC CAD Team was selected due to its operational success in conducting many MRMC CAD studies that have resulted in multiple FDA clearances of CAD Software Bolton, MA, San Antoni...

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

PubMed Articles [915 Associated PubMed Articles listed on BioPortfolio]

Self-Determination Theory: Intrinsic Motivation and Behavioral Change.

Motivation is a central concept in behavioral change. This article reviews the self-determination theory with an emphasis on "intrinsic motivation," which is facilitated when three basic psychological...

Population pharmacokinetics of ospemifene and safety evaluation of pharmacokinetic alterations caused by intrinsic and extrinsic factors

To develop a population pharmacokinetic (PPK) model to assess factors influencing ospemifene pharmacokinetics and to assess safety for pharmacokinetic alteration observed in drug development.

Local Intrinsic Dimension Estimation by Generalized Linear Modeling.

We propose a method for intrinsic dimension estimation. By fitting the power of distance from an inspection point and the number of samples included inside a ball with a radius equal to the distance, ...

Inhibition of EZH2 or BET Suppresses Diffuse Intrinsic Pontine Glioma.

H3K27M-expressing diffuse intrinsic pontine gliomas (DIPG) are dependent on residual PRC2 activity.

Orthogonal self-guided similarity preserving projection for classification and clustering.

A suitable feature representation can faithfully preserve the intrinsic structure of data. However, traditional dimensionality reduction (DR) methods commonly use the original input features to define...

Clinical Trials [252 Associated Clinical Trials listed on BioPortfolio]

Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?

Vitamin B12 is an essential nutrient for normal DNA-synthesis and must be supplied by animal products. Vitamin B12 deficiency may cause anemia and irreverible neurological damage. Laborato...

PI EGFRvIII Peptide Vaccination After Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas

This is a research study of patients with diffuse intrinsic pontine gliomas. We hope to learn about the safety and efficacy of treating pediatric diffuse intrinsic pontine glioma patients...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

INTRINSIC RV - Inhibition of Unnecessary RV Pacing With AV Search Hysteresis in ICDs

INTRINSIC RV is a two-armed randomized trial that will compare the effects of innovative dual-chamber pacing with AV Search Hysteresis to standard VVI among ICD patients.

Panobinostat in Treating Younger Patients With Progressive Diffuse Intrinsic Pontine Glioma

This phase I trial studies the side effects and best dose of panobinostat in treating younger patients with diffuse intrinsic pontine glioma that is growing, spreading, or getting worse (p...

Companies [1161 Associated Companies listed on BioPortfolio]

Intrinsic Therapeutics, Inc.

Intrinsic Therapeutics is dedicated to treating soft-tissue injuries of the spine. Intrinsic's Barricaid anular reconstructive products are used during discectomy to definitively close defects in the ...

Intrinsic Bioprobes, Inc.

Intrinsic LifeSciences

Intrinsic LifeSciences, The BioIron Company™, is a privately held California-based company focused on developing innovative tests that help improve the diagnosis and treatmen...

AGY Therapeutics Incorporated

AGY is an emerging biopharmaceutical company, discovering and developing novel treatments for diseases of the nervous system. AGY scientists have established and utilized a unique mechanism-based appr...


Founded in 2002, HealOr is a privately owned, clinical-stage specialty biopharmaceutical company developing a first-in-class pipeline of topical therapeutics to treat a variety of...

More Information about "Intrinsic Therapeutics, Inc." on BioPortfolio

We have published hundreds of Intrinsic Therapeutics, Inc. news stories on BioPortfolio along with dozens of Intrinsic Therapeutics, Inc. Clinical Trials and PubMed Articles about Intrinsic Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intrinsic Therapeutics, Inc. Companies in our database. You can also find out about relevant Intrinsic Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topic

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Corporate Database Quicklinks

Searches Linking to this Company Record